Short Interest in Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) Declines By 99.8%

Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 400 shares, a drop of 99.8% from the September 30th total of 175,900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Hua Medicine (Shanghai) Stock Performance

HUMDF stock remained flat at C$0.15 during trading on Friday. The firm has a fifty day moving average price of C$0.18 and a 200-day moving average price of C$0.20. Hua Medicine has a 12-month low of C$0.15 and a 12-month high of C$0.15.

Hua Medicine (Shanghai) Company Profile

Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D.